Skip to content

Author

N. Nouhravesh

We have 3 of 79 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

The antifibrotic effect of empagliflozin: Insights from the EMPIRE trial programme

Treatment with empagliflozin significantly decreased levels of circulating PRO-C3, reflecting attenuated systemic fibroblast activation, and to what extent this indicated antifibrotic effect may underpin the clinical effects of empagliflozin remains to be elucidated.

J. Jensen, C. Andersen, M. Omar et al. · 0 citations
Aug 2026

Venous thromboembolism in 5-year cancer survivors: a nationwide cohort study.

Survivors of all 21 cancer subtypes had a higher associated rate of VTE compared with the background population, with the highest incidence rates found for multiple myeloma.

A. Yafasova, Guo-Li Sun, M. Hutchings et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.